Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 4:24 PM
Ignite Modification Date:
2025-12-25 @ 2:18 PM
NCT ID:
NCT03217266
Pre Assignment Details:
This is a two-step study in which all participants start one week of treatment at Step 1 at the current dose escalation level while p53 status is determined, but Step 2 assigns the full/remaining course of treatment and determines the intended analysis population: participants with wild-type p53 (Group I) continue on navtemadlin for the purpose of the study analysis, while the rest of participants (Group II) discontinue navtemadlin and are not included in endpoint analyses.
Study:
NCT03217266
Study Brief:
Results Section:
NCT03217266